KFGN Klinische Forschung Hannover- Mitte GmbH
Hanover 30159
0 studies enrolling now · 1 studies all time
What they study most
Clostridium Difficile
Studies at this site
Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study
— Completed